Cite

HARVARD Citation

    Miyamoto, T. et al. (2022). Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*. Leukemia & lymphoma. 63 (4), pp. 928-938. [Online]. 
  
Back to record